Psoriatic Arthritis: Symptoms, Types, Early Signs & Why to Act Quickly
Psoriatic arthritis (PsA) is a chronic inflammatory joint condition that affects approximately 20–30% of people with psoriasis. Unlike musculoskeletal pain from injury or age-related wear, psoriatic arthritis involves immune-mediated joint inflammation — the same immune dysregulation driving skin plaques can also attack the joints, tendons, ligaments, and spine.
The most important single fact about psoriatic arthritis: without appropriate treatment, it can cause irreversible joint damage. Unlike psoriasis, where flares can resolve leaving the skin largely unchanged, active joint inflammation in PsA causes structural changes — erosion of joint surfaces, bone remodelling, and tendon damage — that don't reverse when inflammation is treated later. Early recognition and treatment is directly protective of long-term joint function.
Who develops psoriatic arthritis and when
Approximately 1 in 4 people with psoriasis will develop psoriatic arthritis at some point. It most commonly develops between the ages of 30 and 50, though it can occur at any age, including in children.
The relationship between skin and joint disease is not predictable:
Around 85% of people with psoriatic arthritis have skin psoriasis first, typically appearing 10 years before joint symptoms. About 15% develop joint symptoms before or at the same time as skin psoriasis — some without visible plaques at the time of joint diagnosis. Severe or nail psoriasis is associated with higher risk of joint involvement. Family history of psoriasis or psoriatic arthritis increases risk.
The five subtypes: why psoriatic arthritis presents differently in different people
Psoriatic arthritis is classified into five clinical subtypes, which explains why the condition looks very different between individuals:
Asymmetric oligoarticular (most common, approximately 50% of cases) — affects four or fewer joints, typically on different sides of the body. May affect large joints like the knee or hip asymmetrically, or individual fingers or toes.
Symmetric polyarticular (approximately 25%) — affects five or more joints on both sides of the body, often resembling rheumatoid arthritis in its pattern. Tends to be more aggressive.
Distal interphalangeal (DIP) predominant — affects the joints at the tips of the fingers and toes, closest to the nails. Often accompanied by nail psoriasis. This pattern is quite specific to psoriatic arthritis and distinct from rheumatoid arthritis (which typically spares the DIP joints).
Spondylitis (approximately 5%) — affects the spine and sacroiliac joints, producing inflammatory back pain and stiffness. Can occur with or without peripheral joint involvement.
Arthritis mutilans (rarest, less than 5%) — a severe, destructive form causing significant deformity of the small joints. Associated with the telescoping "opera glass" finger deformity. Aggressive early treatment is most critical in this subtype.
Dactylitis: the sausage digit
Dactylitis — swelling of an entire finger or toe to produce a "sausage digit" appearance — is one of the most distinctive features of psoriatic arthritis, occurring in approximately 30–40% of patients.
The mechanism explains the distinctive appearance: in psoriatic arthritis, the tendon sheath that surrounds the flexor tendons of the fingers becomes inflamed (tenosynovitis) simultaneously with the joints themselves. This produces diffuse swelling along the entire length of the digit — including its soft tissues — rather than localised joint swelling. This is distinct from the discrete joint swelling of rheumatoid arthritis and is strongly suggestive of psoriatic arthritis specifically when present alongside psoriasis.
Dactylitis in psoriatic arthritis is associated with more severe joint disease and a higher risk of erosive damage.
Enthesitis: the most specific PsA feature
Enthesitis — inflammation at the sites where tendons and ligaments attach to bone — is present in approximately 30–50% of people with psoriatic arthritis and is one of the features that most specifically distinguishes it from rheumatoid arthritis.
Common enthesitis sites in PsA include: the Achilles tendon attachment at the heel (producing heel pain), the plantar fascia attachment at the heel (producing pain on the first steps in the morning), the patellar tendon at the knee, and the elbows.
Enthesitis pain is typically worse with prolonged rest and the first movements of the day — the characteristic "start-up" pain — and may be mistaken for plantar fasciitis, Achilles tendinopathy, or other local mechanical conditions rather than being recognised as part of a systemic inflammatory condition.
If you have psoriasis and persistent heel pain, pain in the soles of your feet, or tendon pain at multiple sites without obvious mechanical cause, enthesitis is worth raising with a GP.
Other features to know
Nail psoriasis and joint disease. Nail involvement (pitting, thickening, onycholysis) in psoriasis is associated with approximately three times the risk of psoriatic arthritis compared to psoriasis without nail involvement. The DIP joint and nail bed share blood supply and immune tissue — this anatomical connection explains the clinical association.
Uveitis. Eye inflammation (uveitis) occurs in approximately 7% of people with psoriatic arthritis. It presents as a painful red eye with light sensitivity and requires urgent ophthalmological assessment. Uveitis in the context of psoriasis or psoriatic arthritis should not be assumed to be conjunctivitis.
Inflammatory back pain. Spinal PsA produces inflammatory rather than mechanical back pain — typically worse with rest and improved with activity, waking the person in the second half of the night, and associated with morning stiffness lasting more than 30 minutes. This pattern distinguishes inflammatory from mechanical back pain and warrants investigation.
Diagnosis: the CASPAR criteria
The Classification Criteria for Psoriatic Arthritis (CASPAR) provide a structured diagnostic framework. A patient is classified as having psoriatic arthritis if they have inflammatory joint disease plus three or more of the following:
Current psoriasis, a personal history of psoriasis, or a family history. Nail dystrophy (pitting, onycholysis, or hyperkeratosis). Negative rheumatoid factor. Dactylitis (current or documented history). Radiographic evidence of new bone formation adjacent to joints.
The CASPAR criteria are used in research and specialist assessment. In practice, GP-level assessment looking for the combination of psoriasis, joint symptoms, enthesitis, and dactylitis guides referral to rheumatology for formal diagnosis and management.
Why early treatment matters
This deserves specific emphasis. Research has found that a delay of six months or more from symptom onset to treatment is associated with significantly worse long-term joint outcomes — more erosive damage, reduced physical function, and lower quality of life at follow-up.
Joint erosions in psoriatic arthritis are irreversible. Unlike skin plaques that can clear and recur without permanent structural change, joints that have been eroded don't regenerate. The period between symptom onset and treatment initiation is the window during which damage accumulates.
This is why anyone with psoriasis who develops joint pain, morning stiffness lasting more than 30 minutes, dactylitis, or enthesitis symptoms should seek GP assessment promptly rather than assuming it's general musculoskeletal pain. Most GPs will refer to rheumatology — where DMARDs (methotrexate, sulphasalazine) and biologics (TNF-α inhibitors, IL-17 inhibitors, IL-23 inhibitors) are the appropriate treatment decisions.
Recommended Products
Vegetology Opti3 Omega-3 EPA & DHA
an algae-derived EPA and DHA supplement with documented anti-inflammatory effects on joint inflammation through leukotriene pathway reduction. As noted above, some evidence exists specifically for psoriatic arthritis benefit. Appropriate for vegetarians and vegans.
Solgar UC-II Collagen
undenatured Type II collagen specifically relevant to cartilage integrity and immune modulation in inflammatory arthritis. As covered in the collagen and psoriasis article in this series, Type II collagen addresses the joint cartilage dimension that Type I supplements don't.
Supplement Support for Psoriasis-Prone Skin
Several nutritional factors have documented relevance to psoriatic arthritis:
Omega-3 EPA/DHA — have documented anti-inflammatory effects on joint inflammation through leukotriene pathway reduction. Some evidence for modest benefit in psoriatic arthritis specifically.
Type II collagen (UC-II) — may support cartilage integrity and modulate immune responses to joint collagen. Covered in the collagen and psoriasis article in this series.
Vitamin D — consistently lower in psoriatic arthritis patients; has immune regulatory effects relevant to both skin and joint disease.
Drought's Skin Support Formula provides vitamin D, zinc, magnesium, vitamin C, and other nutrients relevant to skin and immune function — complementing appropriate medical treatment rather than substituting for it. Made in the UK, suitable for vegetarians, designed for consistent long-term daily use.
FAQ
What are the first signs of psoriatic arthritis?
Morning stiffness lasting more than 30 minutes, joint pain that improves with activity, swelling of an entire finger or toe (dactylitis), heel pain on first steps in the morning (enthesitis), and nail changes alongside psoriasis.
Is morning stiffness common with psoriatic arthritis?
Yes — and its specific character distinguishes inflammatory from mechanical joint pain. Morning stiffness in psoriatic arthritis typically lasts more than 30 minutes and improves with movement and activity — the opposite of mechanical joint pain which often worsens with activity and improves with rest. Stiffness lasting more than 30 minutes after waking, or returning after periods of sitting, is one of the clinical red flags that should prompt GP assessment in anyone with psoriasis. The inflammatory mechanism involves cytokine accumulation in joint fluid during inactivity that dissipates with movement — explaining both the morning severity and the activity-related improvement.
Can psoriasis affect the joints?
Yes — through the same Th17 immune dysregulation driving skin plaques. TNF-α, IL-17, and IL-23 — the cytokines targeted by biologic psoriasis treatments — drive inflammatory damage in joints, tendon sheaths, and entheses simultaneously. This is why biologics prescribed for skin psoriasis (secukinumab targeting IL-17, guselkumab targeting IL-23) also treat psoriatic arthritis — they address the shared inflammatory mechanism. Around 20–30% of people with psoriasis develop psoriatic arthritis, and joint damage can progress independently of skin disease severity — mild skin psoriasis doesn't exclude significant joint disease.
What joints does psoriatic arthritis affect?
Commonly affected areas include the fingers, toes, knees, ankles, wrists, and lower back.
Does psoriatic arthritis cause permanent joint damage?
Yes — without appropriate treatment, active joint inflammation causes irreversible erosion of joint surfaces. Early diagnosis and treatment significantly reduces this risk.
Can you have psoriatic arthritis without obvious psoriasis?
Yes — approximately 15% of people with PsA develop joint symptoms before significant skin psoriasis, and some have only nail psoriasis or minimal skin involvement.
What is dactylitis?
Swelling of an entire finger or toe to produce a "sausage" appearance — caused by simultaneous inflammation of the tendon sheath and joints of the digit. Strongly suggestive of psoriatic arthritis.
What is enthesitis?
Inflammation at the sites where tendons and ligaments attach to bone — most commonly at the heel (Achilles tendon, plantar fascia), knee, and elbow. Produces pain worse with rest and improved with movement.
How is psoriatic arthritis diagnosed?
By a rheumatologist using the CASPAR criteria — combining clinical features (inflammatory joint disease, psoriasis history, dactylitis, nail changes, negative rheumatoid factor) and sometimes imaging.
Can nail changes be linked to psoriatic arthritis?
Yes — nail psoriasis is one of the strongest clinical predictors of joint involvement. Nail pitting, onycholysis (nail lifting from the bed), thickening, and discolouration in people with psoriasis are associated with approximately three times the risk of psoriatic arthritis compared to psoriasis without nail involvement. The anatomical explanation is specific: the DIP joint (the joint at the fingertip) and the nail bed share blood supply and immune tissue — inflammation in one is frequently accompanied by inflammation in the other. The DIP-predominant subtype of psoriatic arthritis almost always occurs alongside nail disease for this reason.
Summary
Psoriatic arthritis is a systemic inflammatory condition affecting up to 30% of people with psoriasis, with five distinct subtypes and specific clinical features — dactylitis (whole digit swelling from tendon sheath inflammation), enthesitis (tendon-to-bone attachment inflammation, particularly at the heel), nail involvement, and spinal disease — that distinguish it from other arthritides. The critical message is timing: joint damage is irreversible and accumulates during the period between symptom onset and treatment. Anyone with psoriasis who develops joint pain, morning stiffness lasting more than 30 minutes, sausage fingers or toes, or heel or sole pain without mechanical cause should seek GP assessment promptly.
Written by the Drought Skin team — specialists in natural support for psoriasis, eczema and acne
Disclaimer: This article contains affiliate links. We earn a very small commission from each purchase made through these links. There is no additional cost to you. All products featured have been specifically selected as products we personally use and love. For further information, please see our disclaimer page.
